Social Sentiment Ticker Powered by AI
Social Sentiment Ticker Powered by AI
Download App
Master the Markets with TradeZing PLUS’s AI Powered Tools
Learn More
Host your events on tradezing app
COMMUNITY AUDIO ROOMS
No available audio rooms
Upcoming Events
TradeZing
🔴 Live CPI Inflation Update Live Trading
Welcome to another enlightening episode on Michael Whitman’s channel, where we dive deep into the world of investing, spanning cryptocurrencies, stocks, and forex.
5 Day7 Hr38 Min27 Sec
YouTube
🔴PPI Data Extreme Bitcoin Volatility | Here’s What To Do
Welcome to another enlightening episode on Michael Whitman’s channel, where we dive deep into the world of investing, spanning cryptocurrencies, stocks, and forex.
6 Day7 Hr38 Min27 Sec
YouTube
Bitcoins next massive move will shock investors!!! $BTC $BITI $BITO $HODL $IBIT $ARKB $BTCW $GBTC
Bitcoins next massive move will shock investors!!! $BTC $BITI $BITO $HODL $IBIT $ARKB $BTCW $GBTC
14 Day10 Hr38 Min27 Sec
YouTube
Get the TradeZing Newsletter
Supercharge
Your Money Making Potential
Watch your wealth rise with the power of AI research tools only with TradeZing PLUS!
Subscribe Now
EXCLUSIVE
Trade the Day
With Larry Benedict and Eric Shamilov
Trade together with legendary hedge fund manager Larry Benedict every morning before the bell
Everyday at 8:45 AM EST
What is Trade the Day?
Get ahead of the market curve each trading day with Larry Benedict, a distinguished Barron’s Top 100 hedge fund manager and the founder of the Opportunistic Trader ETF (WZRD). With his analyst, Eric Shamilov, Larry provides live, pre-market trading insights and strategic analysis, equipping you with the knowledge to make smart trading decisions.
Not a TradeZing PRO Member?
Subscribe now for exclusive advantages and benefits!
TZ PLUS Cash Back
Latest Feed
178544
News
May 10, 2024
22 mins ago
Skye Bioscience Highlights Novel Synthetic Cannabinoid-based Library Capable of Modulating the Endocannabinoid System to Treat Ocular Diseases at ARVO 2024 Annual Meeting
Poster presentation details screening approach allowing selection of candidate molecules applicable to dry eye disease and chronic ocular pain, with potential to identify therapeutic candidates with novel mechanisms of action for other ocular pathologies Poster presentation details screening approach allowing selection of candidate molecules applicable to dry eye disease and chronic ocular pain, with potential to identify therapeutic candidates with novel mechanisms of action for other ocular pathologies
178546
News
May 10, 2024
22 mins ago
Instil Bio Reports First Quarter 2024 Financial Results and Provides Corporate Update
DALLAS, May 10, 2024 (GLOBE NEWSWIRE) — Instil Bio, Inc. (“Instil”) (Nasdaq: TIL), a clinical-stage biopharmaceutical company focused on developing a pipeline of novel therapies, today reported its first quarter 2024 financial results and provided a corporate update.
178545
News
Related on Reddit
Related on X
Related on YouTube
Catalyst Watch: This Beaten-Down, High-Yield Dividend Stock Is Working on a Long-Term Solution to Its Biggest Issue
NextEra Energy Partners is working to address the looming buyouts of its remaining convertible equity portfolio financing.
Continue Reading
Copied
Related Events
No related events associated to this feed.
Latest Feed
May 10, 2024
17 mins ago
Inspired Reports First Quarter 2024 Results
This is an earnings release.
INSE
178544
News
May 10, 2024
22 mins ago
Skye Bioscience Highlights Novel Synthetic Cannabinoid-based Library Capable of Modulating the Endocannabinoid System to Treat Ocular Diseases at ARVO 2024 Annual Meeting
Poster presentation details screening approach allowing selection of candidate molecules applicable to dry eye disease and chronic ocular pain, with potential to identify therapeutic candidates with novel mechanisms of action for other ocular pathologies Poster presentation details screening approach allowing selection of candidate molecules applicable to dry eye disease and chronic ocular pain, with potential to identify therapeutic candidates with novel mechanisms of action for other ocular pathologies
SKYE
178546
News
May 10, 2024
22 mins ago
Instil Bio Reports First Quarter 2024 Financial Results and Provides Corporate Update
DALLAS, May 10, 2024 (GLOBE NEWSWIRE) — Instil Bio, Inc. (“Instil”) (Nasdaq: TIL), a clinical-stage biopharmaceutical company focused on developing a pipeline of novel therapies, today reported its first quarter 2024 financial results and provided a corporate update.
TIL
178545
News
Related on Reddit
Related on X
Related on YouTube
Connect with your community
Introducing Audio Rooms: Engage in real-time discussions on community or news topics with fellow users. Each article or post can instantly create its exclusive audio room, facilitating conversations about subjects directly tied to the article or community post.
Audio Room Title:
Catalyst Watch: This Beaten-Down, High-Yield Dividend Stock Is Working on a Long-Term Solution to Its Biggest Issue
Someone already created an audio of this feed.
Join the room
How it Works
Seeking Alpha
Bezinga
Market Rebellion
Motley Fool
And More!
Not a TradeZing PLUS Member?
Subscribe now for exclusive advantages and benefits!
How it Works
Seeking Alpha
Bezinga
Market Rebellion
Motley Fool
And More!
Not a TradeZing PLUS Member?
Subscribe now for exclusive advantages and benefits!
0 Comments